Historial de revisiones de «Acute generalized exanthematous pustulosis»

11 dic 2024

• actant 16:1516:15 11 dic 2024‎ Rossdonaldson1 discusión contribs.‎ 1265 bytes +35‎ →‎Background

22 feb 2021

• actant 22:3522:35 22 feb 2021‎ Elcatracho discusión contribs.‎ 1230 bytes +3‎ →‎Management
• actant 22:3522:35 22 feb 2021‎ Elcatracho discusión contribs.‎ 1227 bytes +4‎ →‎Evaluation
• actant 22:3422:34 22 feb 2021‎ Elcatracho discusión contribs.‎ 1223 bytes +4‎ →‎Clinical Features

17 dic 2019

• actant 19:1819:18 17 dic 2019‎ Rossdonaldson1 discusión contribs.‎ 1219 bytes +65‎ →‎Evaluation

27 nov 2019

• actant 02:3302:33 27 nov 2019‎ Rossdonaldson1 discusión contribs.‎ 1154 bytes −26‎ →‎Differential Diagnosis
• actant 02:3102:31 27 nov 2019‎ Rossdonaldson1 discusión contribs.‎ 1180 bytes −15‎ →‎Differential Diagnosis
• actant 02:2602:26 27 nov 2019‎ Rossdonaldson1 discusión contribs.‎ 1195 bytes −18‎ →‎Differential Diagnosis
• actant 02:2602:26 27 nov 2019‎ Rossdonaldson1 discusión contribs.‎ 1213 bytes −103‎ →‎Differential Diagnosis
• actant 02:2602:26 27 nov 2019‎ Rossdonaldson1 discusión contribs.‎ 1316 bytes −46‎ →‎Differential Diagnosis
• actant 01:2801:28 27 nov 2019‎ Rossdonaldson1 discusión contribs.‎ 1362 bytes +27‎ →‎Differential Diagnosis
• actant 01:2701:27 27 nov 2019‎ Rossdonaldson1 discusión contribs.‎ 1335 bytes +65‎ Sin resumen de edición

31 oct 2019

• actant 17:3617:36 31 oct 2019‎ Jaydengalamgam discusión contribs.‎ 1270 bytes −4‎ Sin resumen de edición

11 dic 2016

• actant 05:0605:06 11 dic 2016‎ ClaireLewis discusión contribs.‎ 1274 bytes +71‎ →‎Clinical Features

• actant 05:0505:05 11 dic 2016‎ ClaireLewis discusión contribs.‎ 1203 bytes +1203‎ Created page with "==Background== *T-cell mediated rash with systemic features *>90% of cases attributable to a medication (usually an antibiotic) *Mortality rate of ~5% ==Clinical Features..."